Stocks and Investing
Stocks and Investing
Mon, April 29, 2019
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Fri, April 26, 2019
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Liana Moussatos Maintained (BMRN) at Buy with Increased Target to $128 on, Apr 26th, 2019
Liana Moussatos of Wedbush, Maintained "BioMarin Pharmaceutical Inc." (BMRN) at Buy with Increased Target from $127 to $128 on, Apr 26th, 2019.
Liana has made no other calls on BMRN in the last 4 months.
There is 1 other peer that has a rating on BMRN. Out of the 1 peers that are also analyzing BMRN, 0 agree with Liana's Rating of Hold.
This is the rating of the analyst that currently disagrees with Liana
- Laura Chico of "Raymond James" Initiated at Buy and Held Target at $110 on, Tuesday, April 9th, 2019